Invitation to Annual General Meeting of Shareholders


The Board of Directors of Active Biotech AB (publ) has today issued a notification of the Annual General Meeting, which is to take place at 5 pm on 26 April 2006 at the company's premises at Scheelevägen 22 in Lund. The notification is published in today's editions of Sydsvenskan, Dagens Industri and Post- och Inrikes Tidningar.
Lund 28 March, 2006
Active Biotech AB is a biotechnology company focusing on research and development of pharmaceuticals. Active Biotech has a strong R&D portfolio with pipeline products focused on autoimmune/inflammatory diseases and cancer. Most advanced projects are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, as well as ANYARA for use in cancer immunotherapy with the primary indication non-small cell lung cancer. Further key projects in clinical development comprise the three orally administered compounds TASQ for prostate cancer 57-57 for SLE and RhuDex® for RA.

Active Biotech AB (corp. reg. no. 556223-9227)
Box 724, 220 07 Lund
Tel +46 (0) 46-19 20 00
Fax +46 (0) 46-19 20 50
Shareholders in Active Biotech AB (publ) are hereby invited to the Annual Shareholders' Meeting to be held on Wednesday, 26 April 2006 at 5 p.m. at the company's premises at Scheelevägen 22 in Lund, Sweden.

Shareholders who wish to participate in the shareholders' meeting must (a) be recorded in the register of shareholders kept by VPC AB on Thursday, 20 April 2006 and (b) notify the company of their intention to participate in the shareholders' meeting no later than 4 p.m. on Thursday, 20 April 2006.
Shareholders whose shares are registered in the name of a nominee, through the trust department of a bank or similar institution, must, in order to be entitled to participate in the shareholders' meeting, request that their shares are temporarily re-registered in their own names in the register of shareholders kept by VPC AB. Such registration must be effected no later than Thursday, 20 April 2006. Shareholders must inform their nominees of the re-registration well before this date.
Notice of participation can be made in writing to Active Biotech AB (publ), attn. Susanne Jönsson, Box 724, SE-220 07 Lund, Sweden, by fax +46 46 19 20 50, by telephone +46 46 19 20 00 or by email The notice shall include name, personal/corporate identity number, number of shares held, daytime telephone number and, if applicable, the number of assistants (two at the most) that will accompany the shareholder at the shareholders' meeting. Shareholders who will be represented by proxy and representatives of legal entities, are requested to submit a power of attorney and other authorization documents well before the shareholders' meeting.